Cardiac Pathways gets go-ahead for ablation catheters:
This article was originally published in Clinica
Executive Summary
Cardiac Pathways has received pre-market approval (PMA) for its Chillirpm cooled ablation catheters, including the company's Real-time Position Management navigation technology. The device includes a bi-directional steering capability and integrates the company's ultrasound transducer technology for dynamic real-time catheter navigation and visualisation. The PMA provides the additional approval necessary to use the RPM technology for therapy, the Sunnyvale, California-based company said.